| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |